1. Home
  2. PKOH vs ABVX Comparison

PKOH vs ABVX Comparison

Compare PKOH & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PKOH
  • ABVX
  • Stock Information
  • Founded
  • PKOH 1907
  • ABVX 2013
  • Country
  • PKOH United States
  • ABVX France
  • Employees
  • PKOH N/A
  • ABVX N/A
  • Industry
  • PKOH Industrial Specialties
  • ABVX
  • Sector
  • PKOH Industrials
  • ABVX
  • Exchange
  • PKOH Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • PKOH 355.7M
  • ABVX 407.6M
  • IPO Year
  • PKOH N/A
  • ABVX N/A
  • Fundamental
  • Price
  • PKOH $21.77
  • ABVX $5.89
  • Analyst Decision
  • PKOH
  • ABVX Buy
  • Analyst Count
  • PKOH 0
  • ABVX 8
  • Target Price
  • PKOH N/A
  • ABVX $34.63
  • AVG Volume (30 Days)
  • PKOH 26.3K
  • ABVX 328.4K
  • Earning Date
  • PKOH 03-05-2025
  • ABVX 03-24-2025
  • Dividend Yield
  • PKOH 2.31%
  • ABVX N/A
  • EPS Growth
  • PKOH 284.21
  • ABVX N/A
  • EPS
  • PKOH 2.40
  • ABVX N/A
  • Revenue
  • PKOH $1,656,200,000.00
  • ABVX $11,172,999.00
  • Revenue This Year
  • PKOH $7.84
  • ABVX $371.31
  • Revenue Next Year
  • PKOH $3.92
  • ABVX N/A
  • P/E Ratio
  • PKOH $6.77
  • ABVX N/A
  • Revenue Growth
  • PKOH N/A
  • ABVX 135.94
  • 52 Week Low
  • PKOH $21.00
  • ABVX $5.50
  • 52 Week High
  • PKOH $34.50
  • ABVX $16.63
  • Technical
  • Relative Strength Index (RSI)
  • PKOH 41.38
  • ABVX 36.23
  • Support Level
  • PKOH $21.00
  • ABVX $5.60
  • Resistance Level
  • PKOH $22.79
  • ABVX $7.85
  • Average True Range (ATR)
  • PKOH 0.85
  • ABVX 0.61
  • MACD
  • PKOH 0.06
  • ABVX -0.09
  • Stochastic Oscillator
  • PKOH 37.75
  • ABVX 12.89

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives most of the revenue from the Supply Technologies segment which provides the customer with total supply management services such as engineering and design support, supplier selection, quality assurance, barcoding, product packaging and tracking, just-in-time and point-of-use delivery and electronic billing services for a range of production components.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: